Pharmaceutical products manufacturing and distribution across medical sectors such as Cardiology and Neurology.
Annual revenue $318,421 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About HN Cure Pharma

HN Cure Pharma is a company. HN Cure Pharma offers products and services including BQUIT 0.5 and HNOR.

Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $318.42 K (USD)
    25.37
    as on Mar 31, 2023
  • Net Profit
    $22.94 K (USD)
    288.21
    as on Mar 31, 2023
  • EBITDA
    $77.2 K (USD)
    848.38
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of HN Cure Pharma

HN Cure Pharma offers a comprehensive portfolio of products and services, including BQUIT 0.5 and HNOR.

Product name locked
Category locked
Primary

This product is manufactured for use in specific therapeutic applications within the pharmaceutical industry.

Product name locked
Category locked
Locked

This product is offered as part of the range in various therapy segments like those related to health and wellness.

Funding Insights of HN Cure Pharma

Premium access

Detailed funding history for HN Cure Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by HN Cure Pharma

Investments
Premium access

Investment portfolio details for HN Cure Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - HN Cure Pharma

Premium access

Detailed financials for HN Cure Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Hn Cure Pharma Comparisons

HN Cure Pharma Primary company
Description
Pharmaceutical products manufacturing and distribution acros...
Location
-
Founded Year
-
Annual Revenue
$318.42 K (USD)
Net Profit
$22.94 K (USD)
EBITDA
$77.2 K (USD)
Employees
Not available
Premium access

Peer comparison for HN Cure Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of HN Cure Pharma

Premium access

Detailed competitors of HN Cure Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Hn Cure Pharma

Premium access

Complete news archive for HN Cure Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about HN Cure Pharma

Annual revenue of HN Cure Pharma is $318.42K as on Mar 31, 2023.

HN Cure Pharma is recognized as a steadily growing pharmaceutical company that offers products across therapy segments including Cardiology, Neurology, Urology, Endocrinology, Orthopedics, Ophthalmology, Gynecology, Gastroenterology, IVF, Oncology, Dermatology, and Psychiatry. All products are produced under strict quality control to comply with the highest industry standards, and the company is certified as an ISO 9001:2015 entity. Testimonials indicate that trust is placed in HN Cure Pharma by patients and families, with innovation being pursued through collaborations involving scientists, doctors, and business teams to address market needs. This approach is noted for fostering a sustainable quality culture.

HN Cure Pharma offers BQUIT 0.5 and HNOR.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available